ʻO ka weheweheʻana
ʻO ka helu o ka waena o ka waena o ka waena o ka waena .02-02-3 Hoʻohanaʻia kēia poloka hale nui e hana i ka fexuprazan kūpono a me ka ahonui, me ka hoʻomaʻemaʻe kiʻekiʻe, hana ia i kahi hana kiʻekiʻe.
ʻO A-Amaino-2,4-difcohortlacetlachecetic acid ka nui o nā wahi crystalline maikaʻi maikaʻi me ka maʻemaʻe nui. Ua hiki i kona mau mea kiʻekiʻe kiʻekiʻe ke loaʻa i ka synthesis i maʻalahi a kūlike i ka fexuprazan, e hōʻoia ana i ka huahana hope loa e hoʻokō i nā koina o nā mea kūʻai aku.
Koho iā mākou
ʻO Jdk i nā hale hana mua o nā papa mua a me nā mea hoʻokele waiwai kūpono, e hōʻoia ana i ka nui o ka pono o ka API i kauʻia. ʻO ka hui loea e hoʻopiʻi iā R & D o ka huahana. E kū'ē iā lāua, keʻimi nei mākou no CMM & CDMO ma ka hale kūʻai home a me ka mākeke honua.